课题基金 / 基金详情

项目摘要

项目成果

COLIN Edward BISHOP的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overriding hypothesis of this application is that the generation and characterization of non Human primate (NHP) induced pluripotent stem cell lines (iPS) will hasten the development of replacement tissues and organs in Humans. Macaque monkeys share an extremely close phylogenetic relationship with Man, and develop natural or experimentally induced disease states which accurately mimic the Human condition. NHPs can provide a unique preclinical model to test the usefulness of iPS cells and regenerative medicine approaches to the treatment and cure of disease, where other models may fail. The ability to generate autologous, pluripotent stem cells from skin fibroblasts, by relatively simple reprogramming steps, is a quantum scientific advance which will have major ramifications in many areas of basic research and applied clinical medicine. It is highly unlikely, however, that the use of viral vectors in the reprogramming protocol (as it exists now) will be acceptable for use in patients. It is vital, therefore, that alternative ways of reprogramming, without virus, be investigated. The short 11 amino acid protein transduction domain (PTD) derived from the HIV transactivator, TAT has been used to deliver large (~110kD), biologically active proteins directly into cells in vitro and in vivo. TAT fusion proteins and peptides have also been used to treat mouse models of cancer, inflammation and other diseases. It is our hypothesis that recombinant TAT and be able to reprogram cells into a pluripotent state. Once well characterized, lines derived by viral or protein transduction methods can be used in NHP preclinical models for a number of different diseases. We therefore propose to: (1) generate induced pluripotent stem cell lines (iPS) from the non-human primate, Macaca fascicularis (cynomolgus macaque) (2) To determine if M. fascicularis iPS cells can be produced non-virally using recombinant proteins modified with an HIV derived, TAT cell penetrating motif to aid in protein translocation across the plasma membrane and (3) characterize and compare iPS lines generated by viral and protein transduction.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jviromet.2010.07.026
发表时间: 2010-11
期刊: Journal of virological methods
影响因子: 3.1
作者: [Pan C, Lan X, Chen H, Bishop CE]
通讯作者: Bishop CE
DOI: 10.1016/s1673-8527(09)60042-4
发表时间: 2010-04
期刊: JOURNAL OF GENETICS AND GENOMICS
影响因子: 5.9
作者: [Pan, Chuanying, Hicks, Amy, Guan, Xuan, Chen, Hong, Bishop, Colin E.]
通讯作者: Bishop, Colin E.
Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC.
使用 HIV-1 TAT 重组蛋白 OCT4、SOX2、KLF4 和 c-MYC 重编程人成纤维细胞
DOI: 10.1007/s11033-009-9680-6
发表时间: 2010-04
期刊: Molecular biology reports
影响因子: 2.8
作者: [Pan C, Lu B, Chen H, Bishop CE]
通讯作者: Bishop CE
DOI: 10.1016/j.gene.2014.11.061
发表时间: 2015-02-10
期刊: GENE
影响因子: 3.5
作者: [Pan, Chuanying, Jia, Wenchao, Lu, Baisong, Bishop, Colin E.]
通讯作者: Bishop, Colin E.
Development of normal and dystrophic canine iPS lines
Pluripotency of Amniotic Fluid-Derived Stem Cells
Pluripotency of Amniotic Fluid-Derived Stem Cells
TISSUE PROCUREMENT AND MOLECULAR TECHNIQUES
  • 批准号:
    7030578
  • 项目类别:
  • 资助金额:
    $10.42万
  • 财政年份:
    2006
  • 负责人:
    COLIN Edward BISHOP
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: